OneMedNet Corporation Secures $2.5 Million Through Private Placement for Corporate Expansion and Working Capital

Reuters
24 Jun
<a href="https://laohu8.com/S/ONMD">OneMedNet</a> Corporation Secures $2.5 Million Through Private Placement for Corporate Expansion and Working Capital

OneMedNet Corporation has announced a private placement agreement with an accredited investor for the issuance and sale of 3,390,923 shares of common stock and pre-funded warrants to acquire an additional 2,561,457 shares. Each share and warrant is priced at $0.42, generating approximately $2.5 million in gross proceeds. The company plans to utilize these funds for general corporate purposes and working capital. The investor has entered a voting agreement to align with the board's recommendations on shareholder proposals. Additionally, OneMedNet has made separate agreements with Dr. Thomas Kosasa and Dr. Jeffrey Yu for the sale of more shares, securing further investment.

Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Onemednet Corporation published the original content used to generate this news brief via EDGAR, the Electronic Data Gathering, Analysis, and Retrieval system operated by the U.S. Securities and Exchange Commission (Ref. ID: 0001641172-25-016223), on June 24, 2025, and is solely responsible for the information contained therein.

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Most Discussed

  1. 1
     
     
     
     
  2. 2
     
     
     
     
  3. 3
     
     
     
     
  4. 4
     
     
     
     
  5. 5
     
     
     
     
  6. 6
     
     
     
     
  7. 7
     
     
     
     
  8. 8
     
     
     
     
  9. 9
     
     
     
     
  10. 10